Modern diabetes technologies like personal insulin pumps and continuous glucose monitoring can help to minimize the deteriorating effect of JIA exacerbations and rheumatoid treatment on metabolic control of diabetes (97). This evidence concerns the gene INS and diabetes mellitus.